2022-2025 National Strategy for Preventing Infections and Antibiotic Resistance

The 2022-2025 National Strategy for Preventing Infections and Antibiotic Resistance is a national cross-sectoral strategy of France. Its main objectives are adoption by the general public of the principles of preventing infections and antibiotic resistance; improve learning about infection prevention and antibiotic resistance from as early as possible; raising public awareness of the prevention of community-acquired and healthcare-associated infections and antibiotic stewardship; consolidating the role of national/regional organisations and user representatives in national and regional schemes; from public users of the healthcare system to health sector professionals: providing the required continuity for preventing infections and antibiotic resistance; developing the patient partnership for the prevention of infections and antibiotic resistance; improving training for health and medicosocial professionals/administrators in the prevention of infections and antibiotic resistance; improving the prevention of infections and antibiotic resistance among healthcare professionals throughout the patient healthcare pathway; encouraging healthcare professionals to implement and promote preventive measures against infections and antibiotic resistance; encouraging antibiotic stewardship among professionals; development of the regional network for infection prevention and control and antibiotic stewardship; developing territorial networks for the prevention of infections and antibiotic resistance; improving the synergy between IPC and ABS measures; shared use of health and monitoring data for taking action; making available useful indicators for the different actors (health authorities, health professionals) to guide the national, regional and local strategy; improving monitoring and sharing best practices; promoting innovative research; developing a sense of “environmental protection” in infection and antibiotic resistance prevention measures; developing and maintaining products that contribute to preventing infections and controlling antibiotic resistance; and contributing to France’s international influence and visibility.